Pharmaceutical Technology Editorial Advisory Board
Pharmaceutical Technology North America and Pharmaceutical Technology Europe magazines publish contributed technical articles that undergo a double-blind peer-review process involving members of our distinguished Editorial Advisory Boards (EAB). The EAB are specialists representing various facets of the pharmaceutical industry. EAB members review manuscripts, recommend subject matter and answer questions when they arise.
- Larry L. Augsburger, PhD, Professor Emeritus, University of Maryland School of Pharmacy
- Reinhard Baumfalk, Head of Product Development LPS, Sartorius
- Phil Borman, DSc, CChem, FRSC, Senior Director QbD & Digital Platform Portfolio & Technology Delivery, Medicine Development & Supply, Pharma R&D, GSK
- Evonne Brennan, Consultant at Evonne Brennan Consulting
- Rory Budihandojo, Independent GMP Consultant
- Christopher Burgess, Managing Director, Burgess Analytical Consultancy
- Metin Çelik, PhD, President, Pharmaceutical Technologies International (PTI)
- Robert Dream, Managing Director, HDR Company
- Sanjay Garg, PhD, Professor and Director, Centre for Pharmaceutical
Innovation and Development, University of South Australia - Filipe Gaspar, Vice-President Technology Intensification
Hovione - Ruey-ching (Richard) Hwang, PhD, Executive Director, Clinical Supply Operations, Pfizer Global R&D
- Henrik Johanning, CEO, Senior Consultant, Genau & More A/S
- Mansoor A. Khan, PhD, Regents Professor and Vice Dean, Presidential Impact Fellow, Rangel College of Pharmacy, Texas A&M University
- Heidi M. Mansour, PhD, Professor, Center for Translational Science, FIU Center for Translational Science
- R. Christian Moreton, PhD, Partner, FinnBrit Consulting
- Fernando J. Muzzio, PhD, Distinguished Professor, Chemical and Biochemical, Engineering Rutgers University
- Christa Myers, Senior Fellow–Aseptic & Sterile Products, CRB
- Moheb M. Nasr, PhD, Principal, Nasr Pharma Regulatory Consulting
- Siegfried Schmitt, PhD, Vice‑President Technical, PAREXEL International
- Susan. J. Schniepp, Distinguished Fellow, Regulatory Compliance Associates. Click HERE for a spotlight on Sue Schniepp.
- David R. Schoneker, President, Black Diamond Regulatory Consulting
- Aloka Srinivasan, Principal and Managing Partner, RAAHA LLC
- Griet Van Vaerenbergh, Marketing Manager Pharma Solid Dosage, GEA Process Engineering
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
